Meta Biomed Co., Ltd. (KOSDAQ:059210)

Meta Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	165,024	84,852	99,718	52,832	66,184	64,352
Market Cap Growth	28.22%	-14.91%	88.74%	-20.17%	2.85%	-0.69%
Enterprise Value	163,361	95,997	130,453	76,546	89,589	96,285
Last Close Price	6200.00	3710.00	4324.16	2280.03	2828.33	2729.28
PE Ratio	9.08	3.79	9.89	20.11	6.95	-
PS Ratio	1.66	0.90	1.20	0.77	1.13	1.43
PB Ratio	1.45	0.88	1.37	0.83	1.10	1.30
P/TBV Ratio	1.49	0.93	1.46	0.91	1.16	1.38
P/FCF Ratio	16.34	7.24	-	-	7.30	24.43
P/OCF Ratio	8.08	3.75	9.76	5.77	5.94	13.24
EV/Sales Ratio	1.64	1.02	1.57	1.11	1.52	2.14
EV/EBITDA Ratio	5.79	4.32	8.80	8.30	10.14	14.92
EV/EBIT Ratio	7.09	5.57	12.30	14.27	17.03	38.30
EV/FCF Ratio	16.18	8.19	-	-	9.88	36.55
Debt / Equity Ratio	0.41	0.58	0.61	0.70	0.57	1.01
Debt / EBITDA Ratio	1.70	2.53	3.00	4.78	3.90	7.73
Debt / FCF Ratio	4.59	4.79	-	-	3.80	18.95
Asset Turnover	0.57	0.61	0.66	0.62	0.56	0.43
Inventory Turnover	2.66	2.73	2.99	2.65	2.10	1.58
Quick Ratio	1.07	0.94	0.71	0.75	0.76	0.70
Current Ratio	1.49	1.28	1.12	1.14	1.20	1.10
Return on Equity (ROE)	17.74%	26.25%	14.74%	4.61%	17.37%	-5.92%
Return on Assets (ROA)	7.97%	7.00%	5.28%	2.99%	3.12%	1.49%
Return on Capital (ROIC)	9.21%	7.99%	5.90%	3.32%	3.39%	1.63%
Return on Capital Employed (ROCE)	18.90%	16.60%	12.40%	7.00%	8.10%	4.20%
Earnings Yield	10.66%	26.40%	10.11%	4.97%	14.39%	-6.36%
FCF Yield	6.12%	13.81%	-1.27%	-11.80%	13.70%	4.09%
Dividend Yield	0.47%	0.81%	0.46%	0.88%	0.71%	0.37%
Payout Ratio	4.37%	2.04%	4.54%	17.43%	2.40%	-
Buyback Yield / Dilution	-19.78%	-18.55%	0.06%	0.07%	0.61%	1.08%
Total Shareholder Return	-19.30%	-17.74%	0.53%	0.95%	1.31%	1.44%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.